| Date Filed | Type | Description |
| 02/06/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/25/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/18/2023 |
8-K
| Quarterly results |
| 01/17/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand... |
| 01/05/2023 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 72,000 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Durbin Scott (CEO) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 360,000 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| JORN DEBORA (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 36,000 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Morris Arlene (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 36,000 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Presnell Sharon Collins (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 36,000 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Robbins Jim B (SVP, Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 57,000 restricted stock units
@ $0 |
|
| 12/15/2022 |
8-K
| Quarterly results |
| 12/06/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 12/02/2022 |
8-K
| Quarterly results |
| 12/01/2022 |
8-K
| Quarterly results |
| 11/23/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
DEL AM
| Form DEL AM - Delaying amendment: |
| 11/10/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/10/2022 |
8-K
| Quarterly results |
| 10/26/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/04/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/29/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/27/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/23/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 09/22/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/15/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/01/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|